June brings FDA clearance for Lumvoa, key retina and glaucoma trials, device deals, and hard truths on AI performance in eye care.
|Videos|February 24, 2021
Visualizing the optic disc with D-EYE
Author(s)OT Staff Reports
Rachel Curtis, MD, a fourth-year resident at Queen's University, Kingston, Ontario, Canada, discusses the highlights from a study comparing a smartphone-compatible device versus traditional direct ophthalmoscopy in teaching medical students how to complete an optic nerve examination.
Advertisement
Read the article on this clinical study:
Advertisement
Related to this article
Study finds ChatGPT-5 overpredicts success after macular hole surgery—beating specialists on paper but missing failures.
Diana Canto-Sims, OD, owner of Buena Vista Optical, discusses how Meta's donation of free AI glasses to blind veterans could close longstanding access gaps in low vision care—and where voice-command wearables fit alongside traditional rehabilitation tools.
Bayer acquired Perfuse Therapeutics and its experimental endothelin-blocking eye implant PER-001, and partnered with AI firm Iambic Therapeutics to accelerate small molecule drug discovery.
ARPA-H funds OCULAB to build tear-duct sensors that track biomarkers in real time and microdose drugs, transforming dry-eye and systemic care.
A balanced mix of AI-generated and smartphone-captured images eliminated the domain-specific failures seen with single-source training
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
One day, three approvals: FDA expands options for ocular redness, thyroid eye disease, and presbyopia
2
Matching artificial tears to dry eye phenotype: a Q&A with Omur Ucakhan, MD
3
Women’s Health: Identifying dry eye in rheumatoid arthritis can make all the difference
4
Diabetic macular edema: an inflammatory disease in focus
5